A Concomitant Decrease in Cortical and Trabecular Bone Mass in Isolated Hypogonadotropic Hypogonadism and Gonadal Dysgenesis

Yonsei Medical Journal

Volumn 40, Issue 5, 1999, Pages 444-449

  Park, Ki Hyun ^a   Lee, Sang Joon ^b   Kim, Jin Young ^b   Kim, Jeong Yeon ^a   Bai, Sang Wook ^a   Kim, Jae Wook ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Bone; Density; Hypogonadism

Indexed keywords

COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE I TRIMERIC CROSS LINKED PEPTIDE; COLLAGEN TYPE I TRIMERIC CROSS-LINKED PEPTIDE; OSTEOCALCIN; PEPTIDE;

ADOLESCENT; ADULT; ARTICLE; BLOOD; BONE DENSITY; FEMALE; GONADAL DYSGENESIS; HUMAN; HYPOGONADISM; METABOLISM; PUBERTY;

ADOLESCENT; ADULT; BONE DENSITY; COLLAGEN; COLLAGEN TYPE I; FEMALE; GONADAL DYSGENESIS; HUMANS; HYPOGONADISM; OSTEOCALCIN; PEPTIDES; PUBERTY;

EID: 0033203568     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.1999.40.5.444     Document Type: Article

References (23)

1. Riggs BL, Melton LJ. Involutional osteoporosis. N Engl J Med 1986;314:1676-86.
2. Johson Jr CC, Longscope C. Premenopausal bone loss-a risk factor for osteoporosis. N Engl J Med 1990;323:1271-2.
3. Hui SL, Slemenda CW, Jonston Jr CC. The contribution of bone loss to postmenopausal osteoporosis. Osteoporos Int 1990;1:30-4.
4. Avioli LV. The calcium controversy and the recommended dietary allowance. In: Avioli LV, editor. THE OSTEOPOROTIC SYNDROME Detection, Prevention, and Treatment. 2nd ed. London: M.D. Grun & Stratton, Inc. Harcourt Brace Jovanovich; 1987. p.57-66.
5. Sandler RB, Slemenda CW, Laporte RE, Cauley JA, Schramm MM, Barresi ML, et al. Postmenopausal bone density and milk consumption in childhood and adolescence. Am J Clin Nutr 1985;42:270-4.
6. Davis MC, Hall ML, Jacobs HS. Bone mineral loss in young with amenorrhea Br Med J 1990;301:790-3.
7. Stepan JJ, Musilova J, Pacovsky V. Bone demineralization, biochemicalindices of bone remodeling, and estrogen replacement therapy in adults with Turner's syndrome. J Bone Miner Res 1989;4:193-8.
8. Emans SJ, Grace E, Hoffer FA, Gundberg C, Ravnikar V, Wood ER, et al. Estrogen deficiency in adolescents and young adults:Impact on bone mineral content and effects of estrogen replacement therapy. Obstet Gynecol 1990;76:585-92.
9. Risteli J, Elomaa I, Niemi S, Novamo A, Risteli L. Radioimmunoassay for the pyridinolin cross-linked carboxyl-terminal telopeptide of type 1 collagen: A new serum marker of bone collagen degradation. Clin Chem 1993;39:635-40.
10. Cann CE, Martin MC, Genant HK, Jaffe RB. Decreased spinal mineral content in amenorrheic women. JAMA 1994;251:626-9.
11. Finkelson JS, Klibanski A, Neer RM, Greenspan SL, Rosenthal DI, Crowley WF. Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. Ann Intern Med 1997;106:354-61.
12. Gulekli B, Davies MC, Jacobs HS. Effect of treatment on established osteoporosis in young women with amenorrhea. Clin Endocrinol 1994;41:275-81.
13. Davies MC, Guleki B, Jacobs HS. Osteoporosis in Turner's syndrome and other forms of primary amenorrhea. Clin Endocrinol 1995;43:741-6.
14. Ranke MB, Blum WR, Haug F, Rosendahl W, Attanasio A, Enders H, et al. Growth hormone,somatomedin levels and growth regulation in Turner's syndrome. Acta Endocrinol (Copenh) 1997;116:305-13.
15. Cavelzasio J, Bonjour JP. IGF-1, a key regulator of renal phosphate treatment and 1,25-dihydroxyvitamin D3 Production during growth. NIPS 1991;6:206-10.
16. Gilsanz V, Roe TF, Gibbon DT, Schulz EE, Carlson ME, Gonzalez O, et al. Effect of sex steroids on peak bone density of growing rabbit. Am J Physiol 1988;255: E416-E21.
17. Theintz G, Buchs B, Rizzoli R, Slosman D, Clavien H, Sizonenko PS, et al. Longitudinal monitoring of bone mass accumulation in Healthy Adolescent: Evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects. J Clin Endocrinol Metab 1992;75:1060-5.
18. Finkelstein JS, Klinbanski A, Neer RM, Doppelt SH, Rosendahl DI, Segre GV, et al. Increases in bone density during treatment of men with idiopathic hypogonadotrophic hypogonadism. J Clin Endocrinol Metab 1989;65:53-8.
19. Jackson JA, Kleerekoper M, Parfitt M, Rao DS, Villanueva AR, Frane B. Bone histomorphometry in hypogonadal and eugonadal men with spinal Osteoporosis. J Clin Endocrinol Metab 1987;65:53-8.
20. Parfitt AM. Bone remodeling: Relationship to the amount and structure of bone and the pathogenesis and prevention of fracture. In: Riggs BL, editor. Osteoporosis-Etiology, Diagnosis and Treatment. New York: Raven Press; in press.
21. Brown DM, Jowsey J, Bradford DS. Osteoporosis in ovarian dysgenesis. J Pediatr 1974;84:816-20.
22. Mora S, Weber G, Guarneri MP, Nizzoli G, Pasolini D, Chiumello G. Effect of estrogen therapy on bone mineral content in girls with Turner's syndrome. Obstet Gynecol 1992;79:747-51.
23. Kruse K, Schonau E, Wohlfart K. Effect of hGH on bone metabolism in Ullrich-Turner syndrome. In: Ranke MB, Rasenfeld RG, editors. Turner syndrome: Growth-Promotion Therapies. Amsterdam: Elsevier; 1991. p. 125-30.